Skip to main content

Roche Cobas Liat System

Roche this week announced the launch of its cobas Liat System, a fast, compact molecular diagnostic platform designed for on-demand testing in physician clinics, pharmacies, and hospitals. The PCR-based system is fully automated and can generate test results in as little as 20 minutes, Roche said.

Roche also currently offers two tests on the system: cobas Influenza A/B and cobas Strep A. The Liat system and accompanying assays are both CE marked and cleared by the US Food and Drug Administration. Roche noted that the Liat System is not currently CLIA waived in the US and that testing sites outside the clinical laboratory are not available in all markets.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.